Inhibitor could prevent growth in BRCA1-mutation breast cancer [PreClinical]
1. Breast tissue samples from patients with BRCA1 mutations showed high expression of the protein Receptor Activator of Nuclear...
Corinne is an MD/PhD student and graduate of Spelman College. Currently a PhD candidate in Immunology, Corinne is studying the rare condition of STAT5B deficiency and its associated fatal pulmonary complications. She has fervent interests in nutrition, pediatrics, and education, and aims to combine these three interests along with rare disease research in her future career. When away from the lab, Corinne enjoys cooking, writing poetry, and getting lost in neosoul music.
1. Breast tissue samples from patients with BRCA1 mutations showed high expression of the protein Receptor Activator of Nuclear...
1. Fluorescent reporters for the protein Muashi (Msi) were used for live imaging in mice, and showed that cancer...
1. In multiple rodent models of type 2 diabetes, central injection of fibroblast growth factor 1 (FGF1) normalized blood...
1. The first known bifunctional inhibitor for the mechanistic target of rapamycin (mTOR) protein was developed to overcome current...
1. Blocking Tacc3, a gene involved in mitotic spindle assembly, decreased the proliferation of intestinal stem cells in a...
1. Decreased levels of the molecule butyrate and its receptors were found in mice that received an allogeneic bone...
1. Mice treated with single-walled carbon nanotubes (SWNTs) self-administered less methamphetamine (METH) and showed a decrease in craving and relapse....
1. A helper-dependent adenoviral vector (HDV) was modified with an antibody (a10mab) that specifically targeted molecules on the chondrocyte cell...
1. Dual-function antibodies were designed such that each one bound to the macrophage-specific cell surface receptor F4/80, as well as...
1. In mice, plasmonic nanobubbles (PNBs) specifically targeted and killed cancer cells without damaging normal cells or surrounding tissues....
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.